Drill pipe is hollow, thick-walled piping that transmits drilling fluid and torque through the wellbore to the drill bit on a drilling rig. It is manufactured to withstand severe internal and external ...

Let us know! Philadelphia and Wilmington, along with other United States cities, shared information this week about the location of lead pipes across their neighborhoods. The lead pipe inventories are ...

An example of lead pipes that deliver water to the nation's homes is on display. (Seth Perlman/AP Photo) From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet? On October 2nd, the FDA cleared an investigational new drug (IND ...

Exscientia Plc (EXAI) has released an update. Exscientia plc has entered into a definitive agreement for acquisition by Recursion Pharmaceuticals, with the transaction aimed at combining their ...

Pipe flanges are protruding rims, edges, ribs, or collars used to make a connection between two pipes or between a pipe and any type of fitting or equipment component. Pipe flanges are used for ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals is a TechBio company trying to apply artificial intelligence (AI) to the new drug-discovery process. The first placebo-controlled trial results from Recursion ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Salt Lake City, UT, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will ...

In the latest market close, Recursion Pharmaceuticals (RXRX) reached $6.67, with a -0.74% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.76%.